TRZSX | VTSNX | TRZSX / VTSNX | |
Total Expense Ratio | 0.00 | 0.06 | - |
Annual Report Gross Expense Ratio | 0.65 | 0.06 | 1,083% |
Fund Existence | 6 years | 15 years | - |
Gain YTD | 28.025 | 26.963 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.3B | 526B | 5% |
Annual Yield % from dividends | 2.70 | 2.77 | 98% |
Returns for 1 year | 20.49 | 17.30 | 118% |
Returns for 3 years | 71.43 | 58.35 | 122% |
Returns for 5 years | 71.90 | 48.95 | 147% |
Returns for 10 years | N/A | 74.70 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 151.00 | 1.38 | +0.92% |
iShares Biotechnology ETF | |||
BGY | 5.89 | 0.04 | +0.68% |
BlackRock Enhanced International Dividend Trust | |||
SEEM | 30.58 | 0.08 | +0.28% |
SEI Select Emerging Markets Equity ETF | |||
AVMU | 45.54 | 0.03 | +0.08% |
Avantis Core Municipal Fixed Inc ETF | |||
XTAP | 39.70 | 0.02 | +0.05% |
Innovator US Equity Acltd Pls ETF™ April |